Get started
Live feed
·
SECFilingvia Quantisnow
Johnson & Johnson logo

JNJ: SEC Form 10-Q filed by Johnson & Johnson

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for JNJ

Across the 23 sessions after earlier JNJ headlines, the stock closed higher 12 times and lower 11 times, with a median move of 1.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

JNJ close-to-close change in the session after earlier headlines
SessionEarlier headlineJNJSPY
Jul 23, 2026TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma+1.4%-1.2%
Jul 22, 2026Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System+2.0%-0.1%
Jul 16, 2026Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Awardand 1 other headline that session+1.2%-0.5%
Jul 15, 2026Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026and 1 other headline that session-2.7%+0.4%
Jul 8, 2026Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform-1.4%-0.3%
Jun 26, 2026Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis+4.0%-0.7%
Quantisnow market dataNYSE
Johnson & Johnson logo
JNJ
Johnson & Johnson
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for JNJ

Follow JNJ and get a push notification the moment its next story breaks.

Full JNJ profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JNJ (Johnson & Johnson) and more on Quantisnow.